Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,945 | 18 | 53.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,045 | 11 | 20.1% |
| Travel and Lodging | $21,234 | 22 | 19.4% |
| Food and Beverage | $7,340 | 132 | 6.7% |
| Education | $37.59 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $71,306 | 70 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $14,232 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $11,368 | 1 | $0 (2023) |
| Electromed, Inc. | $5,768 | 51 | $0 (2024) |
| Gilead Sciences, Inc. | $2,956 | 9 | $0 (2019) |
| Genentech, Inc. | $1,980 | 1 | $0 (2023) |
| Philips Electronics North America Corporation | $674.38 | 11 | $0 (2021) |
| AstraZeneca UK Limited | $537.00 | 1 | $0 (2024) |
| Allergan Inc. | $262.35 | 3 | $0 (2018) |
| Alcresta Therapeutics, Inc. | $130.77 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,272 | 31 | Insmed, Inc. ($16,758) |
| 2023 | $40,910 | 30 | Insmed, Inc. ($24,596) |
| 2022 | $11,198 | 23 | Insmed, Inc. ($7,433) |
| 2021 | $1,733 | 19 | Insmed, Inc. ($937.38) |
| 2020 | $7,836 | 12 | Insmed, Inc. ($7,602) |
| 2019 | $15,419 | 27 | Insmed, Inc. ($13,980) |
| 2018 | $1,888 | 20 | Vertex Pharmaceuticals Incorporated ($1,159) |
| 2017 | $4,345 | 23 | Gilead Sciences Inc ($2,944) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Airway Clearance Device | ||||||
| 12/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $128.69 | General |
| Category: HFCWO | ||||||
| 11/12/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: HFCWO | ||||||
| 10/11/2024 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,060.00 | General |
| 10/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | KALYDECO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,180.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 10/09/2024 | Electromed, Inc. | SMARTVEST (Device) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: HFCWO | ||||||
| 10/09/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $115.45 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | VERTEX PHARMACEUTICALS INCORPORATED | KALYDECO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 09/25/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $81.08 | General |
| Category: HFCWO | ||||||
| 09/22/2024 | Insmed, Inc. | — | Travel and Lodging | In-kind items and services | $457.26 | General |
| 09/22/2024 | Insmed, Inc. | — | Travel and Lodging | In-kind items and services | $318.88 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 09/21/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 09/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 09/20/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/20/2024 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 09/18/2024 | Insmed, Inc. | — | Travel and Lodging | In-kind items and services | $812.96 | General |
| 08/28/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $47.25 | General |
| Category: HFCWO | ||||||
| 08/21/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| 07/11/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $31.67 | General |
| Category: HFCWO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 616 | 750 | $98,543 | $27,065 |
| 2022 | 6 | 317 | 399 | $55,097 | $14,501 |
| 2021 | 9 | 234 | 403 | $120,892 | $32,569 |
| 2020 | 5 | 144 | 308 | $126,183 | $33,657 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 112 | $33,264 | $9,998 | 30.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 72 | $15,120 | $4,272 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 43 | 50 | $12,300 | $3,537 | 28.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 15 | $10,200 | $2,405 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 23 | $8,027 | $2,385 | 29.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 216 | 219 | $5,037 | $1,334 | 26.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $3,668 | $1,196 | 32.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 156 | 157 | $5,966 | $1,036 | 17.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 77 | 77 | $3,927 | $690.69 | 17.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 11 | $1,034 | $210.65 | 20.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 120 | $35,640 | $9,545 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 32 | $7,872 | $2,305 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 11 | $3,839 | $1,118 | 29.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 115 | 117 | $2,691 | $686.45 | 25.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 77 | 78 | $2,964 | $501.98 | 16.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 41 | 41 | $2,091 | $343.84 | 16.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 41 | 155 | $46,035 | $12,251 | 26.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 31 | 65 | $44,200 | $11,117 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 46 | 55 | $13,530 | $3,798 | 28.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 24 | $8,376 | $2,688 | 32.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 16 | 20 | $4,300 | $1,579 | 36.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 11 | $1,947 | $618.53 | 31.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 30 | 31 | $713.00 | $197.70 | 27.7% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 26 | 27 | $1,026 | $186.16 | 18.1% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 15 | 15 | $765.00 | $134.96 | 17.6% |
About George Solomon
George Solomon is a Critical Care Medicine healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316140403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, George Solomon has received a total of $109,602 in payments from pharmaceutical and medical device companies, with $26,272 received in 2024. These payments were reported across 185 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($58,945).
As a Medicare-enrolled provider, Solomon has provided services to 1,311 Medicare beneficiaries, totaling 1,860 services with total Medicare billing of $107,792. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Location Birmingham, AL
- Active Since 06/07/2007
- Last Updated 06/29/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1316140403
Products in Payments
- SMARTVEST (Device) $5,768
- KALYDECO (Drug) $5,305
- Arikayce (Drug) $4,585
- Cayston (Drug) $2,932
- (8874) inCourage (Device) $484.69
- AVYCAZ (Drug) $262.35
- Wellcentive Undiv (Device) $172.70
- RELIZORB (Device) $130.77
- DUOPA (Drug) $100.56
- Pulmozyme (Biological) $54.80
- ORKAMBI (Drug) $34.00
- BRONCHITOL (Drug) $33.14
- Hillrom - Volara System (Device) $28.68
- Cipro (Drug) $24.33
- Hillrom - Vest System Model 105 Home Care (Device) $18.02
- MITRACLIP (Device) $17.65
- Respiratoriy Care Undiv (Device) $16.99
- Venclose Maven Catheter (Device) $13.61
- ZERBAXA (Drug) $12.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Birmingham
Mark Dransfield
Critical Care Medicine — Payments: $388,806
James Wells
Critical Care Medicine — Payments: $206,948
Tracy Luckhardt
Critical Care Medicine — Payments: $51,348
Joseph Barney
Critical Care Medicine — Payments: $30,178
Peter Morris, Md, MD
Critical Care Medicine — Payments: $22,246
Erin Ozgun, M.d, M.D
Critical Care Medicine — Payments: $15,945